Merck has announced that its chairman Richard Clark will retire from the company and the board of directors.
The news comes after Clark stepped down from his role as president and CEO, handing over to Kenneth Frazier. In his stead, Frazier will also become chairman.
Clark said: "I have been a part of Merck for more than 39 years – I always have and always will consider Merck to be an important part of my life and my extended family.”
UCB has more than drugs in its 2015 pipeline, while BUPA and biotechs hire new recruits.
Simon Sturge leaves Boehringer Ingelheim to head Merck's biosimilars unit, as well as the European Medicines Agency,...
All change at biopharmas this week, as we reveal the industry movers at four biologics firms. Plus,...
Changes at Novo Nordisk, Questcor, Nicox and more in this week's column.
This week's People on the Move column sees leadership appointments at two major trade bodies, as well...